missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human Latent TGF-beta 1 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Marke: R&D Systems™ 299-LT-025/CF
Dieser Artikel kann nicht zurückgegeben werden.
Rückgaberichtlinie anzeigen
Beschreibung
The Recombinant Human Latent TGF-beta 1 Protein is derived from CHO. The Recombinant Human Latent TGF-beta 1 Protein has been validated for the following applications: Bioactivity.Spezifikation
| Supplied as a 0.2μm filtered solution in PBS and Glycerol. | |
| Observed Molecular Wt: 40-43kDa & 12kDa, reducing conditions 80-90kDa, non-reducing conditions, Predicted Molecular Wt.: 41.3kDa (monomer) | |
| 25 μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after opening. 3 months, ≤ -20° C under sterile conditions after opening. | |
| <1.0 EU per 1μg of the protein by the LAL method. | |
| Unconjugated | |
| 97%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
| 7040 | |
| Latent TGF-beta 1 | |
| Chinese Hamster Ovary cell line,CHO-derived human TGF-beta 1 protein Leu30-Ser390 | |
| Leu30 & Ala279 |
|
| CEDLAP, DPD1, latency-associated peptide, TGF beta1, TGFB, TGFB1, TGFbeta, TGFbeta 1, TGF-beta 1 protein, TGF-beta-1, transforming growth factor beta-1, transforming growth factor, beta 1 | |
| Recombinant |
Berichtigung von Produktinhalten
Bitte geben Sie uns Ihr Feedback zu den Produktinhalten, indem Sie das folgende Formular ausfüllen.
Name des Produkts
Haben Sie Verbesserungsvorschläge?Übermitteln Sie eine inhaltliche Korrektur